Rhythm Pharmaceuticals, Inc. Common Stock —— 图表、价格与新闻 (NASDAQ:RYTM) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

Market Capitalization 5.9599 B
Employee 414
Founded N/A
CEO N/A
Website www.rhythmtx.com
Headquarter Delaware, United States
FIGI BBG007DLZ601
Industry Technology

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

5.96 B 市值

市盈率

-34.42

市销率

36.66

新闻

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity - Slideshow (NASDAQ:RYTM) 2026-03-24

Rhythm Surges On A New Obesity Approval; How It Edged In Where Lilly, Novo 'Have Fallen Flat'

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity Transcript

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Rhythm Pharmaceuticals Misses The Beat In Obesity, But There's A Caveat

Needham因试验失败下调Rhythm Pharmaceuticals目标价

Needham cuts Rhythm Pharmaceuticals stock price target on trial miss

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial - Slideshow (NASDAQ:RYTM) 2026-03-17

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial Transcript

Rhythm Pharma shares fall as obesity drug trial fails to meet main goal

Stifel重申Rhythm Pharmaceuticals股票评级为买入